Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this ...

IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC Holdings" or the "Company") has launched Ignite Proteomics LLC ("Ignite"), its new subsidiary dedicated to helping ...

Proteins drive cell behavior and are the direct targets of many new cancer drugs, especially antibody-drug conjugates (ADCs) ...

Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...

A range of current precision oncology clinical trials are reliant on customized, targeted NGS-panel assays in order to ...

First-of-its-kind research looking at survival rates for patients with incurable larynx cancer has been published. A groundbreaking study has uncovered molecular markers in blood at birth that are ...

But now, researchers have developed a promising new treatment method that can change the way cancer is treated using a special hydrogel that delivers medication directly to the tumor, reducing the ...

If you have stage 1 kidney cancer, the tumor has not spread from the kidney and is less than 7 centimeters (cm), or approximately 2.7 inches, large. Stage 1 kidney cancer may be cured through surgical ...